Cyclo(RGDfK(NHS)) is the activated ester form of Cyclo(-RGDfK) (HY-P0023). Cyclo(-RGDfK) is a potent and selective inhibitor of the alphavbeta3 integrin, with an IC50 of 0.94 nM. Cyclo(-RGDfK) potently targets tumor microvasculature and cancer cells through the specific binding to the alphavbeta3 integrin on the cell surface[1][2].
Molecular Weight:
700.74
Formula:
C31H44N10O9
Target:
Integrin
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
